ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Marvin M. Kirsh
Herbert Sloan
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirsh, M. M.
Right arrow Articles by Sloan, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirsh, M. M.
Right arrow Articles by Sloan, H.

Ann Thorac Surg 1982;34:34-39
© 1982 The Society of Thoracic Surgeons

Articles

Carcinoma of the Lung in Women

Marvin M. Kirsh, M.D.*, Jeanne Tashian, M.A., Herbert Sloan, M.D.

From the Section of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI

* Address reprint requests to Dr. Kirsh, C7079 University Hospital, Ann Arbor, MI 48109

The 5-year survival of 293 men and of 78 women undergoing pulmonary resection and mediastinal lymph node dissection is compared. These patients were broken into two age groups: Group 1, 40 through 49 years of age, and Group 2,50 years of age and older. They were subdivided further according to clinical stage, cell type, and sex.

Of the 25 men in Group 1, 15 (60%) survived 5 years, while 98 (37%) of the 268 men in Group 2 survived 5 years. Among the 31 women in Group 1, 5 (16%) survived for 5 years, while 15 (32%) of the 47 women in Group 2 survived for that length of time. The survival among women in the younger age group was significantly lower than for both groups of women in the older age group (p = 0.0335) and men in the younger age group (p = 0.0033). This is believed to be due to the higher incidence of both Stage III disease and adenocarcinoma in the younger women. Twenty-two of the younger women (71%) were classified Stage III compared with 14 (30%) of the older women. Fourteen younger men (56%) had reached Stage III, and 101 older men (38%) were classified as Stage III.

These data suggest that sex is an important factor in determining survival because there appears to be a relationship between it and the stage of the disease, and cell type. Overall, women had a poorer 5-year survival than men. Younger women have a strikingly lower survival than any other group, which is explained by their higher incidence of both Stage III classification and adenocarcinoma.




This article has been cited by other articles:


Home page
 Am J Clin PatholHome page
W. Sterlacci, A. Tzankov, L. Veits, W. Oberaigner, T. Schmid, W. Hilbe, and M. Fiegl
The Prognostic Impact of Sex on Surgically Resected Non-Small Cell Lung Cancer Depends on Clinicopathologic Characteristics
Am J Clin Pathol, April 1, 2011; 135(4): 611 - 618.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
P.-h. Wang, H.-c. Wang, and C.-c. Tsai
Estrogen Replacement in Female Lung Cancer During Gefitinib Therapy
Jpn. J. Clin. Oncol., December 1, 2009; 39(12): 829 - 832.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
J. M. Weiss, J. V. Lacey Jr., X.-O. Shu, B.-T. Ji, L. Hou, G. Yang, H. Li, N. Rothman, A. Blair, Y.-T. Gao, et al.
Menstrual and Reproductive Factors in Association With Lung Cancer in Female Lifetime Nonsmokers
Am. J. Epidemiol., December 1, 2008; 168(11): 1319 - 1325.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
C.-T. Wu, Y.-L. Chang, J.-Y. Shih, and Y.-C. Lee
The significance of estrogen receptor {beta} in 301 surgically treated non-small cell lung cancers
J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 979 - 986.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
G. E. Goodman, M. D. Thornquist, J. Balmes, M. R. Cullen, F. L. Meyskens Jr., G. S. Omenn, B. Valanis, and J. H. Williams Jr.
The Beta-Carotene and Retinol Efficacy Trial: Incidence of Lung Cancer and Cardiovascular Disease Mortality During 6-Year Follow-up After Stopping {beta}-Carotene and Retinol Supplements
J Natl Cancer Inst, December 1, 2004; 96(23): 1743 - 1750.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. J. Barnes
The Changing Face of Lung Cancer
Chest, December 1, 2004; 126(6): 1718 - 1721.
[Full Text] [PDF]

Home page
 Ann OncolHome page
E. Radzikowska, P. Glaz, and K. Roszkowski
Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases
Ann. Onc., July 1, 2002; 13(7): 1087 - 1093.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
H. Minami, M. Yoshimura, Y. Miyamoto, H. Matsuoka, and N. Tsubota
Lung Cancer in Women : Sex-Associated Differences in Survival of Patients Undergoing Resection for Lung Cancer
Chest, December 1, 2000; 118(6): 1603 - 1609.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. Mitsudomi, M. Tateishi, T. Oka, T. Yano, T. Ishida, and K. Sugimachi
Longer survival after resection of non-small cell lung cancer in Japanese women
Ann. Thorac. Surg., November 1, 1989; 48(5): 639 - 642.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1982 by The Society of Thoracic Surgeons.